- Chengdu Shengnuo Biotechnology Co., Ltd., established in July 2001, is located in Dayi County, Chengdu City.
- In addition, shengnuo biopharmaceutical has also participated in the national major new drug creation project “Research on Key Technologies of peptide chemical modification and industrial scale preparation”.
Chengdu Shengnuo Biotechnology Co., Ltd., established in July 2001, is located in Dayi County, Chengdu City.
Its wholly-owned subsidiary is Chengdu shengnuo biopharmaceutical Co., Ltd. From the initial registered capital of 1 million, to the current huge total assets, the company has achieved sound and rapid development in many years.
It has Chengdu municipal “Chengdu polypeptide drug engineering and technology research center” and has passed the FDA certification of the United States.
It has become a first-class professional peptide drug and product development, technology transfer, technical service, large-scale production and export of peptide medicine industrial park.
Over the years, shengnuo biopharmaceutical has successfully established a technology and management team with senior industry personnel such as high education and senior engineers as the backbone, and has successively won the top innovation and entrepreneurship team of “national high tech enterprise”, “Sichuan enterprise technology center”, “member unit of Sichuan strategic emerging industry promotion association” and “thousand talents plan” of Sichuan Province ”And other honorary titles.
At present, shengnuo biopharmaceutical has formed a close strategic partnership with Sichuan University, Lanzhou University, Jilin University, Academy of Military Sciences, organic Institute of Chinese Academy of Sciences, and Provincial Institute of drug control.
It has established “Sichuan Provincial peptide drug engineering technology research center” and “shengnuo biopharmaceutical Sichuan University industry university research joint laboratory”.
In addition, shengnuo biopharmaceutical has also participated in the national major new drug creation project “Research on Key Technologies of peptide chemical modification and industrial scale preparation”.
The project of “new anti heart failure drug nesiritide” funded by the national science and technology small and medium-sized enterprise technology innovation fund has entered the clinical research stage. In 2010, it has obtained the special fund support of Sichuan Provincial Economic Commission for emerging industries Research on the commercialization of peptide drugs.
It has a number of key technologies for large-scale production of polypeptide drugs and products that have been listed at home and abroad, and the single batch output can reach kg level;
it has international leading technologies such as large-scale production technology of thiocyclic peptide, large-scale production technology of carbon cyclic peptide, complex peptide technology, rapid peptide synthesis technology, etc., and has become the leader of domestic peptide industry by virtue of its excellent key technology of peptide synthesis and modification.
For sale, buy peptides, purchase peptides, and buy peptides online, you can find the Chinese peptide company:
Shengnuo Biotechnology is a high-tech China polypeptide manufacturers,who has over 19 years experience for the biotechnology .Our Products involve peptide raw materials,polypeptide drug.
Our 0 defect has passed the FDA certification, and has become the first-class professional polypeptide drug and product development and large-scale production and export industry in China .
Our service scope：peptide synthesis、peptide hormones、peptide medicine、beauty peptide、peptide medicine product、peptide technology transfer、peptide technology service、peptide large-scale production、export of peptide
Thymopentin for Injection、 Thymalfasin for Injection 、 Bivalirudin 、Bulk Drug、 Liraglutide ……